Collecting cancer patient data in the Campania region
A Retrospective-prospective, Observational, Multicentric Study to Record Data From the ROC Platform and Monitor the ROC Performance
This study is gathering information from cancer patients in the Campania region to see how their treatment and care can be improved.
Quick facts
| Study type | Observational |
|---|---|
| Enrollment | 15000 (estimated) |
| Ages | 18 Years and up |
| Sex | All |
| Sponsor | National Cancer Institute, Naples Academic / other |
| Locations | 17 sites (Avellino, Avellino and 16 other locations) |
| Trial ID | NCT06270602 on ClinicalTrials.gov |
What this trial studies
This observational study aims to create a comprehensive database of cancer patients in the Campania region by collecting both retrospective and prospective data through the ROC platform. It involves multiple oncology centers to ensure a representative cohort, allowing for robust statistical analysis of patient outcomes. The study seeks to enhance understanding of cancer treatment and management in a region with notably poor oncological outcomes. By analyzing this data, the study aims to inform decision-making and improve cancer care strategies.
Who should consider this trial
Good fit: Ideal candidates for this study are cancer patients who have provided informed consent and are registered in the ROC platform.
Not a fit: Patients who are not registered in the ROC platform or who do not provide informed consent may not benefit from this study.
Why it matters
Potential benefit: If successful, this study could lead to improved cancer treatment protocols and better patient outcomes in the Campania region.
How similar studies have performed: Other studies utilizing multicenter databases have shown success in influencing treatment guidelines and improving patient care, indicating that this approach is both tested and promising.
Eligibility criteria
Show full inclusion / exclusion criteria
Inclusion Criteria: * signed informed consent * registration in the ROC platform
Where this trial is running
Avellino, Avellino and 16 other locations
- A.O. Moscati — Avellino, Avellino, Italy (Recruiting)
- Asl Avellino — Avellino, Avellino, Italy (Recruiting)
- A.O. Rummo — Benevento, Benevento, Italy (Recruiting)
- Asl Benevento — Benevento, Benevento, Italy (Recruiting)
- Asl Caserta — Caserta, Caserta, Italy (Recruiting)
- A.O. S.Anna S. Sebastiano — Caserta, Caserta, Italy (Recruiting)
- Asl Napoli 2 Nord — Casavatore, Napoli, Italy (Recruiting)
- Asl Napoli 3 Sud — Ercolano, Napoli, Italy (Recruiting)
- A.O. Cardarelli — Naples, Napoli, Italy (Recruiting)
- A.O. Dei Colli — Naples, Napoli, Italy (Recruiting)
- Federico II — Naples, Napoli, Italy (Recruiting)
- I.N.T. Pascale — Naples, Napoli, Italy (Recruiting)
- A.O.U. Luigi Vanvitelli — Naples, Napoli, Italy (Recruiting)
- Asl Napoli 1 Centro — Naples, Napoli, Italy (Recruiting)
- Ospedale del Mare — Naples, Napoli, Italy (Recruiting)
- Asl Salerno — Salerno, Salerno, Italy (Recruiting)
- A.O.U. Ruggi — Salerno, Salerno, Italy (Recruiting)
Study contacts
- Principal investigator: Sandro Pignata, M.D. — IRCCS I.N.T. "G. Pascale"
- Study coordinator: Sandro Pignata, M.D.
- Email: s.pignata@istitutotumori.na.it
- Phone: 08117770755
How to participate
- Review the eligibility criteria above with your treating physician.
- Visit the official trial page on ClinicalTrials.gov for the most current contact information and recruitment status.
- Contact the listed study coordinator or principal investigator to request pre-screening. Pre-screening is free and never obligates you to enroll.